
"Health wise I am feeling great. I am a big supporter of trials - it allows new treatments and drugs to be brought in.”
This trial wanted to compare the chemotherapy drugs cabazitaxel and docetaxel for prostate cancer that has spread to other parts of the body. The men had prostate cancer that started to get worse after having both hormone therapy and docetaxel.
This trial was supported by Cancer Research UK.
This trial closed early as the researchers were unable to find enough suitable people to take part.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nick James
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Sanofi
University of Birmingham
This is Cancer Research UK trial number CRUKE/12/031.
Freephone 0808 800 4040
"Health wise I am feeling great. I am a big supporter of trials - it allows new treatments and drugs to be brought in.”